Results 71 to 80 of about 249 (106)

Extra-renal role of urate transporter-1 in diabetes. [PDF]

World J Diabetes
Yang TS, Du M, Luo LY, Lin L, Luo XL.
europepmc   +1 more source

Changes in Uric Acid Levels and Effects on Renal Function After Switching From Febuxostat to Dotinurad in Patients With Chronic Kidney Disease: A Retrospective Study. [PDF]

Cureus
Mima A, Matsumoto K, Matsuki T, Morikawa T, Kure S, Akai R, Saito Y, Lee S.   +7 more
europepmc   +1 more source

Intradermal Tophi with Skin Findings Similar to Psoriasis. [PDF]

Intern Med
Terawaki H, Tokita T, Kawagoe K, Ito T.
europepmc   +1 more source

Back to the Physiology: Renal Tubular Handling of Uric Acid and Emerging Strategies for Managing Hyperuricemia. [PDF]

Intern Med
Takata T, Isomoto H.
europepmc   +1 more source

Therapeutic Strategies for Hyperuricemia: From Small-Molecule Inhibitors to RNA Therapeutics. [PDF]

ACS Pharmacol Transl Sci
Yu X, Zhang M, Huang Y.
europepmc   +1 more source

Decoding Adipose Tissue Phenotypic Switching: From Mechanisms to Computational Drug Discovery. [PDF]

Curr Obes Rep
Ye Y, Yin R, Sun J, Dai Y, Zhao D, Zou X.   +5 more
europepmc   +1 more source

Effect of Dotinurad on Serum Uric Acid Concentration in Chronic Kidney Disease Patients Treated with Febuxostat [PDF]

Kashiwagi, Tetsuya, Kurihara, Osamu, Sakai, Yukinao, Yamada, Takehisa, Iwabu, Masato   +4 more
core   +1 more source

Gout management: Patent analytics and computational drug design explores URAT1 inhibitors landscape. [PDF]

PLoS One
Zhang J, Hong L, Xu W, Zhang X, Fu H, Song X, Zhao J.   +6 more
europepmc   +1 more source

The Dual Role of Uric Acid: Pathological Implications Across Chronic Diseases and Current Approaches to Hyperuricemia Management. [PDF]

Discoveries (Craiova)
Zehra A, Asghar A, Ali S, Khalid MU, Shah SIA.   +4 more
europepmc   +1 more source

Transport mechanism and structural pharmacology of human urate transporter URAT1. [PDF]

Cell Res
Dai Y, Lee CH.
europepmc   +1 more source